Wegovy vs Zepbound: which one should I ask for and where do I get either online?

Short answer

• Ask your clinician about both. If your main goal is maximum average weight loss and you have no contraindications, tirzepatide (brand name Zepbound, Eli Lilly) tends to produce larger weight loss in clinical trials than semaglutide (brand name Wegovy, Novo Nordisk). If you prefer a medication with a longer clinical track record for obesity, Wegovy is well established. The best choice depends on your medical history, side‑effect tolerance, cost/insurance, and treatment goals.

Key differences (brief)

• Active drug/class: Wegovy = semaglutide (GLP‑1 receptor agonist). Zepbound = tirzepatide (dual GIP + GLP‑1 receptor agonist).
• Efficacy: In head‑to‑head and separate trials, tirzepatide typically produced larger mean weight loss than semaglutide, but individual responses vary.
• Side effects: Both commonly cause GI effects (nausea, vomiting, diarrhea, constipation). Rates and severity differ by person; tirzepatide can cause more pronounced GI symptoms in some patients.
• Safety cautions: Both carry warnings about thyroid C‑cell tumors in animal studies and are contraindicated with personal/family history of medullary thyroid carcinoma (MTC) or MEN2. Use caution with prior pancreatitis, pregnancy, and significant kidney disease. Your clinician must review your history.

Where to get them online (safe, legitimate options)

1. Start with your own clinician (primary care, endocrinologist, or obesity medicine specialist). They can evaluate you and write a prescription.
2. Manufacturer resources:
   • Wegovy (Novo Nordisk): wegovy.com has patient support and savings program info.
   • Zepbound (Eli Lilly): zepbound.com has product info and patient resources.
3. Reputable telehealth/weight‑management programs that prescribe and ship FDA‑approved Wegovy or Zepbound or manage treatment (examples):
   • Calibrate (calibrate.com) — metabolic health program using GLP‑1/Tirzepatide where appropriate.
   • Ro / Roman (ro.co) — weight‑loss program that can evaluate and prescribe.
   • Hims & Hers (forhers.com or forhims.com) — telehealth prescribing for weight meds in some states.
   • PlushCare (plushcare.com) — primary care/telehealth that may prescribe.
4. Fill prescriptions at accredited pharmacies (CVS, Walgreens, Rite Aid, walmart.com pharmacy, Amazon Pharmacy, or a trusted local pharmacy). You’ll need a valid prescription.
5. Cost help: check manufacturer savings programs (Novo Nordisk for Wegovy, Eli Lilly for Zepbound), GoodRx/SingleCare price comparisons, and your insurer for coverage criteria.

Warnings about unsafe options

• Avoid buying semaglutide/tirzepatide from overseas or compounding pharmacies that sell without prescription — counterfeit or improperly dosed products and poor sterility have been reported.
• Don’t rely on non‑medical “coaches” who sell injections without a licensed prescriber and proper medical oversight.

What to ask your clinician (copy/paste)

• “Based on my medical history (list conditions, meds, pregnancy plans, family history of thyroid cancer), which is better for me: Wegovy (semaglutide) or Zepbound (tirzepatide)?”
• “What side effects should I expect, and how will dosing be escalated?”
• “Will my insurance cover this, and what patient‑savings programs are available?”

If you want, tell me: your age, major medical conditions (esp. diabetes, pancreatitis, thyroid cancer in family), and whether insurance will or won’t cover obesity meds — I can give a more tailored suggestion and practical next steps.